Literature DB >> 27427408

The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia.

Stefania Gessi1, Pier Andrea Borea1, Serena Bencivenni1, Debora Fazzi1, Katia Varani1, Stefania Merighi1.   

Abstract

Increased production of proinflammatory cytokines has a prominent role in tolerance to opioids. The objectives of this study were to examine whether μ-opioid receptor affects proinflammatory signalling through the activation of NF-kB in microglia. The novelty of the described research is that a low dose of morphine, exerting its effects via the μ-opioid receptor, increases the DNA-binding activity of NF-kB via PKCε, while a high dose of morphine triggers a nonopiate receptor response mediated by TLR4 and, interestingly, PKCε signalling. The identification of morphine as a crucial upstream regulator of PKCε-NF-κB signalling in microglia argues for a central role of these pathways in neuroinflammation development and progression. Therefore, the morphine-PKCε-NF-κB pathway may provide novel targets to induce neuroprotective mechanisms, thereby reducing tolerance to opioids.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  Akt; PKCε; mitogen-activated protein kinases; neuroinflammation; nuclear factor-kB; opioid receptor

Mesh:

Substances:

Year:  2016        PMID: 27427408     DOI: 10.1002/1873-3468.12313

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

Review 1.  Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review.

Authors:  Eric A Woodcock; Ansel T Hillmer; Graeme F Mason; Kelly P Cosgrove
Journal:  Mol Neuropsychiatry       Date:  2019-05-09

2.  A cAMP-Related Gene Network in Microglia Is Inversely Regulated by Morphine Tolerance and Withdrawal.

Authors:  Kevin R Coffey; Atom J Lesiak; Russell G Marx; Emily K Vo; Gwenn A Garden; John F Neumaier
Journal:  Biol Psychiatry Glob Open Sci       Date:  2021-08-05

3.  Dorsal hippocampal interleukin-1 signaling mediates heroin withdrawal-enhanced fear learning.

Authors:  Shveta V Parekh; Jacqueline E Paniccia; Christina L Lebonville; Donald T Lysle
Journal:  Psychopharmacology (Berl)       Date:  2020-08-28       Impact factor: 4.530

4.  Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.

Authors:  H H Doyle; A Z Murphy
Journal:  Physiol Behav       Date:  2017-12-01

5.  Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice.

Authors:  Yu-Syuan Wang; Tsai-Wei Hung; Eun-Kyung Bae; Kuo-Jen Wu; Wei Hsieh; Seong-Jin Yu
Journal:  CNS Neurosci Ther       Date:  2021-05-21       Impact factor: 5.243

6.  Hippocampal TNF-α Signaling Mediates Heroin Withdrawal-Enhanced Fear Learning and Withdrawal-Induced Weight Loss.

Authors:  Shveta V Parekh; Jacqueline E Paniccia; Lydia O Adams; Donald T Lysle
Journal:  Mol Neurobiol       Date:  2021-02-13       Impact factor: 5.590

Review 7.  Effect of Opioid Use on Immune Activation and HIV Persistence on ART.

Authors:  Livio Azzoni; David Metzger; Luis J Montaner
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-25       Impact factor: 7.285

8.  MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.

Authors:  Longping Yao; Yongyi Ye; Hengxu Mao; Fengfei Lu; Xiaozheng He; Guohui Lu; Shizhong Zhang
Journal:  J Neuroinflammation       Date:  2018-01-12       Impact factor: 8.322

Review 9.  Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System.

Authors:  Marina Mostafizar; Claudia Cortes-Pérez; Wanda Snow; Jelena Djordjevic; Aida Adlimoghaddam; Benedict C Albensi
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

Review 10.  Modulatory Potential of Cannabidiol on the Opioid-Induced Inflammatory Response.

Authors:  Clare T Johnson; Heather B Bradshaw
Journal:  Cannabis Cannabinoid Res       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.